STANLEY ANDERSON: Open Payments
NPI 1972636306 · NORWICH, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,176 in 73 payments from 12 companies in 2025. Trend: 2023 $570 · 2024 $1,092 · 2025 $1,176
Food & beverage: $1,081Education: $95
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $274 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $226 |
| Janssen Biotech, Inc. | 23 | $225 |
| Lilly USA, LLC | 8 | $126 |
| UCB, Inc. | 4 | $113 |
| Amgen Inc. | 2 | $44 |
| GENZYME CORPORATION | 2 | $36 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
| Arcutis Biotherapeutics, Inc. | 2 | $33 |
| Organon LLC | 1 | $24 |
Products named: SKYRIZI, TREMFYA, ILUMYA, Bimzelx, TALTZ, RINVOQ, OTEZLA, EBGLYSS.
Industry payments across NY — which companies pay providers there.
